Immunohistochemical analysis of the p53 family members in human craniopharyngiomas

Brain Tumor Pathology

Volumn 20, Issue 2, 2003, Pages 73-77

  Momota, Hiroyuki ^a   Ichimiya, Shingo ^a   Ikeda, Tatsuru ^a   Yamaki, Toshiaki ^a   Kikuchi, Tomoki ^a   Houkin, Kiyohiro ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Craniopharyngioma; P53; P63; P73

Indexed keywords

PROTEIN P53; PROTEIN P63; PROTEIN P73;

ADULT; ARTICLE; BASAL CELL; BRAIN TUMOR; CARCINOGENESIS; CELL ACTIVITY; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SELLA TURCICA TUMOR; SQUAMOUS CELL CARCINOMA; TRANSACTIVATION; TUMOR CELL;

ADULT; CHILD; CHILD, PRESCHOOL; CRANIOPHARYNGIOMA; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0742305497     PISSN: 14337398     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02483450     Document Type: Article

References (23)

1. Janzer RC, Burger PC, Giangaspero F, et al (2000) Craniopharyngioma. In: Kleihuse P, Cavenee WK (eds) Pathology and genetics. Tumor of the nervous system. IRAC, Lyon, pp 244-246
2. Xin W, Rubin MA, McKeever PE (2002) Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke cleft cyst. Arch Pathol Lab Med 126:1174-1178
3. Sekine S, Shibata T, Kokubu A, et al (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997-2001
4. Lefranc F, Chevalier C, Vinchon M, et al (2003) Characterization of the levels of expression of retinoic acid receptors, galectin-3, macrophage migration inhibiting factor, and p53 in 51 adamantinomatous craniopharyngiomas. J Neurosurg 98:145-153
5. Rienstein S, Adams EF, Pilzer D, et al (2003) Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg 98:162-164
6. Rickert CH, Paulus W (2003) Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. J Neurol Neurosurg Psychiatry 74:260-261
7. Yang A, Kaghad M, Wang Y, et al (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316
8. Kaghad M, Bonnet H, Yang A, et al (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819
9. Lee LA, Walsh P, Prater CA, et al (1999) Characterization of an autoantigen associated with chronic ulcerative stomatitis: the CUSP autoantigen is a member of the p53 family. J Invest Dermatol 113:146-151
10. De Laurenzi V, Rossi A, Terrinoni A, et al (2000) p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun 273:342-346
11. Di Como CJ, Urist MJ, Babayan I, et al (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494-501
12. Ichimiya S, Kojima T, Momota H, et al (2002) p73 is expressed in human thymic epithelial cells. J Histochem Cytochem 50:455-462
13. van Bokhoven H, Brunner HG (2002) Splitting p63. Am J Hum Genet 71:1-13
14. Yang A, Kaghad M, Caput D, et al (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18:90-95
15. Benard J, Douc-Rasy S, Ahomadegbe JC (2003) TP53 family members and human cancers. Hum Mutat 21:182-191
16. Yang A, Kaghad M, Wang Y, et al (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316
17. Yang A, Walker N, Bronson R, et al (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103
18. Pozniak CD, Radinovic S, Yang A, et al (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289:304-306
19. Liefer KM, Koster MI, Wang XJ, et al (2000) Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 60:4016-4020
20. Hu H, Xia SH, Li AD, et al (2002) Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 102:580-583
21. Hibi K, Trink B, Patturajan M, et al (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97:5462-5467
22. Suliman Y, Opitz OG, Avadhani A, et al (2001) p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice. Cancer Res 61:6467-6473
23. Stiewe T, Putzer BM (2002) Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ 9:237-245